Karuna Therapeutics' top-experimental schizophrenia drug significantly reduced symptoms in a late-stage trial but there were concerns that it could cause hypertension in patients.
Share:
More In Science
FDA Approves New Version of Diabetes Drug Mounjaro for Weight Loss
A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.
One Good Thing: Giant Pandas Head Back to China
One Good Thing: Giant Pandas Head Back to China
India Imposes New Restrictions to Curb Pollution
India Imposes New Restrictions to Curb Pollution
Be Well: How to Improve Your Balance
Exercises to improve your balance.
Be Well: Cleaning Your Pantry and Spice Cabinets
Cleaning Your Pantry and Spice Cabinets
Study: Climate Change is Displacing Native Species
Extreme weather has well-documented effects on humans but a new study points out that it's also impacting the animal kingdom.
Report: Syphilis Cases In Newborns Rise
The CDC released a report with troubling statistics about the number of reported syphilis cases in newborns, with cases rising 10-fold in the last decade and nearly 32% in just one year.
Drugs Aren't Required to Be Tested in People Who Are Obese. Here's Why That's a Problem
More than 40% of American adults are considered obese, yet the medications many take are rarely tested in bigger bodies.
Report: Last Month Was Warmest October on Record
Data collected from European and Japanese research centers show last month was the warmest October on record.
